ArticleThe Journal of clinical investigation2020

MEF2D sustains activation of effector Foxp3+ Tregs during transplant survival and anticancer immunity.

Eros Di Giorgio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.